FDA NDC Directory · JSON-LD · Markdown

Onpattro

NDC 71336-1000 · HUMAN PRESCRIPTION DRUG · INJECTION, LIPID COMPLEX

Generic namepatisiran
Labeler / ManufacturerAlnylam Pharmaceuticals, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA210922
Dosage form / routeINJECTION, LIPID COMPLEX · INTRAVENOUS
Active ingredientsPATISIRAN SODIUM (2 mg/mL)
Marketing started20180813
Package count1

External sources

Source: openFDA. Public-domain (CC0).